BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 20, Issue 48
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (16975)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Tables (1-7) series.
Item 
Count 
PDF1021
WORD451
HTML11943
Tables (1-7)241
 Sum=13656
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1429
Download1889
 Sum=3318
Dec 28, 2014 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Stojsavljević S, Gomerčić Palčić M, Virović Jukić L, Smirčić Duvnjak L, Duvnjak M. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(48): 18070-18091 [PMID: PMC4277948 DOI: 10.3748/wjg.v20.i48.18070]
URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18070.htm
Number Citing Articles
1
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, Giovanni Targher, Christopher D. Byrne, Dan-Qin Sun, Ming-Hua Zheng. Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nature Reviews Nephrology 2022; 18(4): 259 doi: 10.1038/s41581-021-00519-y
2
Sandra Andreotti, Ayumi Cristina Medeiros Komino, Flaviane de Fatima Silva, Ana Paula Almeida Ramos, Noemi Lourenço Gil, Gabriela Araujo Azevedo, Rogerio Antonio Laurato Sertié, Fabio Bessa Lima, Richardt Gama Landgraf, Maristella Almeida Landgraf. Intrauterine food restriction impairs the lipogenesis process in the mesenteric adipocytes from low-birth-weight rats into adulthood. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1259854
3
Shui-Xian Du, Lin-Lin Lu, Yang Liu, Quan-Jiang Dong, Shi-Ying Xuan, Yong-Ning Xin. Association of Adiponectin Gene Polymorphisms With the Risk of Coronary Artery Disease in Patients With Nonalcoholic Fatty Liver Disease in a Chinese Han Population. Hepatitis Monthly 2016; 16(7) doi: 10.5812/hepatmon.37388
4
Huashan Li, Jianying Sheng, Jing Wang, Haiting Gao, Jing Yu, Guoxian Ding, Ning Ding, Weiqi He, Juanmin Zha. Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice. Drug Design, Development and Therapy 2021; : 2309 doi: 10.2147/DDDT.S285828
5
Lorena Bavia, Bruno Cogliati, Juliano Bertollo Dettoni, Venancio Avancini Ferreira Alves, Lourdes Isaac. The complement component C5 promotes liver steatosis and inflammation in murine non-alcoholic liver disease model. Immunology Letters 2016; 177: 53 doi: 10.1016/j.imlet.2016.07.014
6
Cemal Nuri Ercin, Teoman Dogru, Halil Genc, Gurkan Celebi, Fatih Aslan, Hasan Gurel, Muammer Kara, Erdim Sertoglu, Serkan Tapan, Sait Bagci, Manfredi Rizzo, Alper Sonmez. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders 2015; 13(7): 319 doi: 10.1089/met.2015.0018
7
Shigeru Murakami, Ayuko Ono, Azusa Kawasaki, Takaaki Takenaga, Takashi Ito. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro. Amino Acids 2018; 50(9): 1279 doi: 10.1007/s00726-018-2605-8
8
Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver disease. Inflammation Research 2020; 69(9): 851 doi: 10.1007/s00011-020-01373-7
9
Touraj Mahmoudi, Donya Ghorbani, Gholamreza Rezamand, Niloufar Dehestan, Golnaz Jeddi, Asadollah Asadi, Hossein Nobakht, Reza Dabiri, Hamid Farahani, Seidamir Pasha Tabaeian, Mohammad Reza Zali. A Visfatin Gene Promoter Polymorphism (Rs1319501) is Associated With Susceptibility to Nonalcoholic Fatty Liver Disease. Personalized Medicine 2023; 20(2): 157 doi: 10.2217/pme-2022-0100
10
Karen R. Jonscher, Robert B. Rucker. Dietary Interventions in Liver Disease. 2019; : 157 doi: 10.1016/B978-0-12-814466-4.00013-6
11
Silvano Junior Santini, Cristiana Porcu, Giovanni Tarantino, Fernanda Amicarelli, Clara Balsano. Oleuropein overrides liver damage in steatotic mice. Journal of Functional Foods 2020; 65: 103756 doi: 10.1016/j.jff.2019.103756
12
Asad Mirzaei, Asma Asal, Ali Seidkhani-Nahal, Ali Noori-Zadeh. A systematic review and meta-analysis of serum resistin level and its relation to HOMA-IR score using meta-regression in nonalcoholic fatty liver disease patients. Mediterranean Journal of Nutrition and Metabolism 2021; 14(3): 219 doi: 10.3233/MNM-210538
13
Obesity and Breast Cancer: Molecular and Epidemiological Evidence. Journal of Cancer Research Updates 2015; 4(1) doi: 10.6000/1929-2279.2015.04.01.3
14
Noha El Nakeeb, Shereen A Saleh, Yasmine M Massoud, Ahmed Hussein, Rana Hamed. Serum ferritin as a non‐invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non‐alcoholic fatty liver disease. JGH Open 2017; 1(3): 112 doi: 10.1002/jgh3.12019
15
Antonio Olveira, Pedro Herranz, María Luisa Montes. Psoriasis and fatty liver: a harmful synergy. Revista Española de Enfermedades Digestivas 2019; 111: 314 doi: 10.17235/reed.2019.6263/2019
16
Ai‐rong Zhang, Jing Sun, Yuan He, Ning Wang, Li Tian. Attenuation of lipid accumulation in Bel‐7402 cells through ADPN/AMPKα signaling stimulated by Fructus rosae laxae extract. Journal of Food Biochemistry 2020; 44(12) doi: 10.1111/jfbc.13497
17
Chang‐Jiang Yu, Qiu‐Shi Wang, Ming‐Ming Wu, Bin‐Lin Song, Chen Liang, Jie Lou, Liang‐Liang Tang, Xiao‐Di Yu, Na Niu, Xu Yang, Bao‐Long Zhang, Yao Qu, Yang Liu, Zhi‐Chao Dong, Zhi‐Ren Zhang. TRUSS Exacerbates NAFLD Development by Promoting IκBα Degradation in Mice. Hepatology 2018; 68(5): 1769 doi: 10.1002/hep.30066
18
Baran Ghezelbash, Nader Shahrokhi, Mohammad Khaksari, Gholamreza Asadikaram, Maryam Shahrokhi, Sara Shirazpour. Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease. Chinese Journal of Integrative Medicine 2022; 28(6): 531 doi: 10.1007/s11655-022-3307-3
19
Abdelghany Hassan Abdelghany, Mohammad A. BaSalamah, Shakir Idris, Jawwad Ahmad, Bassem Refaat. The fibrolytic potentials of vitamin D and thymoquinone remedial therapies: insights from liver fibrosis established by CCl4 in rats. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-1040-4
20
Sharmin Akter. Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology. Middle East Journal of Digestive Diseases 2022; 14(2): 167 doi: 10.34172/mejdd.2022.270
21
Ji Eun Heo, Dong Gyun Kim, Jeong Woo Yoo, Kwang Suk Lee. Metabolic syndrome-related factors as possible targets for lower urinary tract symptoms in Korean males. The Aging Male 2023; 26(1) doi: 10.1080/13685538.2023.2166920
22
Darmadi Darmadi, Riska Habriel Ruslie. Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD). Romanian Journal of Internal Medicine 2021; 59(1): 66 doi: 10.2478/rjim-2020-0029
23
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
24
Sara Raia, Antonio Conti, Alan Zanardi, Barbara Ferrini, Giulia Maria Scotti, Enrica Gilberti, Giuseppe De Palma, Samuel David, Massimo Alessio. Ceruloplasmin-Deficient Mice Show Dysregulation of Lipid Metabolism in Liver and Adipose Tissue Reduced by a Protein Replacement. International Journal of Molecular Sciences 2023; 24(2): 1150 doi: 10.3390/ijms24021150
25
Noha F. Hassan, Azza H. Hassan, Mona R. El-Ansary. Cytokine modulation by etanercept ameliorates metabolic syndrome and its related complications induced in rats administered a high-fat high-fructose diet. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-24593-9
26
Smitha Krishnan, Yufang Ding, Nima Saedi, Maria Choi, Gautham V. Sridharan, David H. Sherr, Martin L. Yarmush, Robert C. Alaniz, Arul Jayaraman, Kyongbum Lee. Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages. Cell Reports 2018; 23(4): 1099 doi: 10.1016/j.celrep.2018.03.109
27
Jun-Qi Shi, Wen-Xia Shen, Xiang-Zhi Wang, Ke Huang, Chao-Chun Zou. Relationship between immune parameters and non-alcoholic fatty liver disease in obese children. Indian Pediatrics 2017; 54(10): 825 doi: 10.1007/s13312-017-1143-x
28
Aoife N. O’Donovan, Florence M. Herisson, Fiona Fouhy, Paul M. Ryan, Derek Whelan, Crystal N. Johnson, Gaston Cluzel, R. Paul Ross, Catherine Stanton, Noel M. Caplice. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF. American Journal of Physiology-Heart and Circulatory Physiology 2020; 318(3): H590 doi: 10.1152/ajpheart.00512.2019
29
Ayokanmi Ore, Oluseyi Adeboye Akinloye. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions. Medicina 2021; 57(8): 822 doi: 10.3390/medicina57080822
30
Charalampos G. Pontikoglou, Theodosios D. Filippatos, Angelos Matheakakis, Helen A. Papadaki. Steatotic liver disease in the context of hematological malignancies and anti-neoplastic chemotherapy. Metabolism 2024; 160: 156000 doi: 10.1016/j.metabol.2024.156000
31
Adriano Lama, Claudio Pirozzi, Maria Pia Mollica, Giovanna Trinchese, Francesca Di Guida, Gina Cavaliere, Antonio Calignano, Giuseppina Mattace Raso, Roberto Berni Canani, Rosaria Meli. Polyphenol‐rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high‐fat diet fed rats. Molecular Nutrition & Food Research 2017; 61(3) doi: 10.1002/mnfr.201600418
32
Liyun Xu, Wen Liu, Fuxiang Bai, Yong Xu, Xiaohong Liang, Chunhong Ma, Lifen Gao. Hepatic Macrophage as a Key Player in Fatty Liver Disease. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.708978
33
Roberta Gasparro, Giuditta Gambino, Giulia Duca, Danila Di Majo, Valentina Di Liberto, Vincenza Tinnirello, Giulia Urone, Nicolò Ricciardi, Monica Frinchi, Nima Rabienezhad Ganji, Giuseppe Vergilio, Francesco Paolo Zummo, Francesca Rappa, Simona Fontana, Alice Conigliaro, Pierangelo Sardo, Giuseppe Ferraro, Riccardo Alessandro, Stefania Raimondo. Protective effects of lemon nanovesicles: evidence of the Nrf2/HO-1 pathway contribution from in vitro hepatocytes and in vivo high-fat diet-fed rats. Biomedicine & Pharmacotherapy 2024; 180: 117532 doi: 10.1016/j.biopha.2024.117532
34
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Jun Kato, Shiho Tokunaga, Taka-aki Sugihara, Yuichi Hara, Keisuke Hino, Yoshikazu Murawaki, Gonzalo Carrasco-Avino. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model. PLOS ONE 2016; 11(5): e0154676 doi: 10.1371/journal.pone.0154676
35
Lingling Ding, Toon. J. I. De Munck, Yvonne Oligschlaeger, Inês Magro dos Reis, Jef Verbeek, Ger. H. Koek, Tom Houben, Ronit Shiri-Sverdlov. Myosteatosis in NAFLD patients correlates with plasma Cathepsin D. Biomolecular Concepts 2021; 12(1): 27 doi: 10.1515/bmc-2021-0004
36
Ying-Li Liu, Qiu-Zan Zhang, Yan-Rong Wang, Li-Na Fu, Jing-Shu Han, Jing Zhang, Bang-Mao Wang. Astragaloside IV Improves High-Fat Diet–Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.605064
37
Xiaojing Wang, Lan Li, Hongwu Wang, Fang Xiao, Qin Ning. Epoxyeicosatrienoic acids alleviate methionine‐choline‐deficient diet–induced non‐alcoholic steatohepatitis in mice. Scandinavian Journal of Immunology 2019; 90(3) doi: 10.1111/sji.12791
38
Jingyi Guo, Shangyi Huang, Qincheng Yi, Naihua Liu, Tianqi Cui, Siwei Duan, Jiabing Chen, Jiayu Li, Jun Li, Lei Wang, Yong Gao, Guangning Nie. Hepatic Clstn3 Ameliorates Lipid Metabolism Disorders in High Fat Diet-Induced NAFLD through Activation of FXR. ACS Omega 2023; 8(29): 26158 doi: 10.1021/acsomega.3c02347
39
Daqing Zhang, Zhen Mi, Jiya Peng, Tiangui Yang, Yuze Han, Yujia Zhai, Chenliang Song, Xianzhuo Teng, Wei Sun, Jing Guo, Kabeya Paulin Bilonda. Nonalcoholic Fatty Liver Disease as an Emerging Risk Factor and Potential Intervention Target for Atherosclerotic Cardiovascular Diseases. Journal of Cardiovascular Pharmacology 2023; 81(5): 327 doi: 10.1097/FJC.0000000000001418
40
Ji-Young Cha, Da-Hyun Kim, Kyung-Hee Chun. The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Laboratory Animal Research 2018; 34(4): 133 doi: 10.5625/lar.2018.34.4.133
41
Subada Soti, Kathleen E. Corey, Jordan E. Lake, Kristine M. Erlandson. NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?. Current HIV/AIDS Reports 2018; 15(3): 212 doi: 10.1007/s11904-018-0392-1
42
Daniel Costache, Horia Blejan, Damian Cojocaru, Georgiana Ioniță, Marcela Poenaru, Maria Constantin, Andrei Costache, Constantin Căruntu, Daniel Balaban, Raluca Costache. Intersecting Pathways: Nonalcoholic Fatty Liver Disease and Psoriasis Duet—A Comprehensive Review. International Journal of Molecular Sciences 2024; 25(5): 2660 doi: 10.3390/ijms25052660
43
Oliver Glass, Ricardo Henao, Keyur Patel, Cynthia D. Guy, Hans J. Gruss, Wing‐Kin Syn, Cynthia A. Moylan, Robert Streilein, Russell Hall, Anna Mae Diehl, Manal F. Abdelmalek. Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Hepatology Communications 2018; 2(11): 1344 doi: 10.1002/hep4.1237
44
Mariana Verdelho Machado, Anna Mae Diehl. Zakim and Boyer's Hepatology. 2018; : 369 doi: 10.1016/B978-0-323-37591-7.00025-2
45
Georgia Bale, Frédéric Clarembeau, Peter Stärkel, Géraldine Dahlqvist, Yves Horsmans, Nicolas Lanthier. Patients with chronic liver diseases are at risk for diabetes even before development of cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2024; 48(8): 102428 doi: 10.1016/j.clinre.2024.102428
46
Cheng‐Chung Li, Chun Liu, Maobin Fu, Kang‐Quan Hu, Koichi Aizawa, Shingo Takahashi, Suganuma Hiroyuki, Junrui Cheng, Johannes von Lintig, Xiang‐Dong Wang. Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice. Molecular Nutrition & Food Research 2018; 62(8) doi: 10.1002/mnfr.201700738
47
Markos Kalligeros, Linda Henry, Zobair M. Younossi. Metabolic dysfunction-associated steatotic liver disease and its link to cancer. Metabolism 2024; 160: 156004 doi: 10.1016/j.metabol.2024.156004
48
Kimia Mohammadhasani, Mohammad Vahedi Fard, Ali Mottaghi Moghaddam Shahri, Zahra Khorasanchi. Polyphenols improve non‐alcoholic fatty liver disease via gut microbiota: A comprehensive review. Food Science & Nutrition 2024; 12(8): 5341 doi: 10.1002/fsn3.4178
49
Silvia M. Ferolla. Obesity. 2016; : 159 doi: 10.1007/978-3-319-19821-7_13
50
Minghui Zheng, Jing Li, Weizhen Fang, Ling Luo, Rui Ding, Hua Zeng, Hong Luo, Xianghua Lin, Chaohui Duan. The TNF-α rs361525 and IFN-γ rs2430561 polymorphisms are associated with liver cirrhosis risk: a comprehensive meta-analysis. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1129767
51
Amirhossein Tamimi, Mona Javid, Nasrin Sedighi-Pirsaraei, Arian Mirdamadi. Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1420281
52
Hee Jae Lee, Yunsook Lim, Soo Jin Yang. Involvement of resveratrol in crosstalk between adipokine adiponectin and hepatokine fetuin-A in vivo and in vitro. The Journal of Nutritional Biochemistry 2015; 26(11): 1254 doi: 10.1016/j.jnutbio.2015.06.001
53
M. A. Livzan, T. S. Krolevets, S. I. Mozgovoy, N. A. Nikolaev, A. V. Nelidova. Features of intestinal microbiota disorders in the development of metabolic disorders in non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2021; 93(2): 222 doi: 10.26442/00403660.2021.02.200614
54
Gamal A. Salem, Amany Abdel-Rahman Mohamed, Safaa I. Khater, Ahmed E. Noreldin, Manal Alosaimi, Wafa S. Alansari, Ghalia Shamlan, Areej A. Eskandrani, Marwa Mahmoud Awad, Rehab Ahmed Ahmed El-Shaer, Mohamed A. Nassan, Mahmoud Mostafa, Tarek Khamis. Enhancement of biochemical and genomic pathways through lycopene-loaded nano-liposomes: Alleviating insulin resistance, hepatic steatosis, and autophagy in obese rats with non-alcoholic fatty liver disease: Involvement of SMO, GLI-1, and PTCH-1 genes. Gene 2023; 883: 147670 doi: 10.1016/j.gene.2023.147670
55
Doris Ogresta, Anna Mrzljak, Maja Cigrovski Berkovic, Ines Bilic-Curcic, Sanja Stojsavljevic-Shapeski, Lucija Virovic-Jukic. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. Journal of Clinical and Translational Hepatology 2022; 10(2): 339 doi: 10.14218/JCTH.2021.00268
56
Magdalena Losko, Jerzy Kotlinowski, Jolanta Jura. Long Noncoding RNAs in Metabolic Syndrome Related Disorders. Mediators of Inflammation 2016; 2016: 1 doi: 10.1155/2016/5365209
57
Jing Xiong, Xia Chen, Zhijing Zhao, Ying Liao, Ting Zhou, Qian Xiang. A potential link between plasma short‑chain fatty acids, TNF‑α level and disease progression in non‑alcoholic fatty liver disease: A retrospective study. Experimental and Therapeutic Medicine 2022; 24(3) doi: 10.3892/etm.2022.11536
58
Emilia Gore, Emilia Bigaeva, Anouk Oldenburger, Yvette J. M. Jansen, Detlef Schuppan, Miriam Boersema, Jörg F. Rippmann, Andre Broermann, Peter Olinga. Investigating fibrosis and inflammation in an ex vivo NASH murine model. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(2): G336 doi: 10.1152/ajpgi.00209.2019
59
Huicun Zhang, Xiang Gao, Pengmin Chen, Hongbing Wang. Protective Effects of Tiaoganquzhi Decoction in Treating inflammatory Injury of Nonalcoholic Fatty liver Disease by Promoting CGI-58 and Inhibiting Expression of NLRP3 Inflammasome. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.851267
60
Ye Rim Nam, Sae Bom Won, Young-Shin Chung, Chung Shil Kwak, Young Hye Kwon. Inhibitory effects ofDoenjang, Korean traditional fermented soybean paste, on oxidative stress and inflammation in adipose tissue of mice fed a high-fat diet. Nutrition Research and Practice 2015; 9(3): 235 doi: 10.4162/nrp.2015.9.3.235
61
M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity. 2018; : 111 doi: 10.1016/B978-0-12-812504-5.00006-4
62
Toshio Nishi, Yuta Yamamoto, Naoko Yamagishi, Mikitaka Iguchi, Hideyuki Tamai, Takao Ito, Yoshihiro Tsuruo, Masao Ichinose, Masayuki Kitano, Takashi Ueyama. Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats. Journal of Pharmacy and Pharmacology 2018; 70(3): 383 doi: 10.1111/jphp.12870
63
Chifa Ma, Yiwen Liu, Shuli He, Jingbo Zeng, Pingping Li, Chunxiao Ma, Fan Ping, Huabing Zhang, Lingling Xu, Wei Li, Yuxiu Li. C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid Levels. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.600472
64
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Boram Park, Seong Joon An, Joo Sung Kim. Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia. Journal of Korean Medical Science 2020; 35(22) doi: 10.3346/jkms.2020.35.e164
65
P. Shabani, S. Emamgholipour, M. Doosti. . Advances in Clinical Chemistry 2017; 79: 1 doi: 10.1016/bs.acc.2016.10.002
66
Eunhui Seo, Yoon Sin Oh, Hee-Sook Jun. Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice. Nutrients 2016; 8(2): 83 doi: 10.3390/nu8020083
67
Viviana Casagrande, Alessandro Mauriello, Simone Bischetti, Maria Mavilio, Massimo Federici, Rossella Menghini. Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06439-x
68
Ioana Corina Bocsan, Mircea Vasile Milaciu, Raluca Maria Pop, Stefan Cristian Vesa, Lorena Ciumarnean, Daniela Maria Matei, Anca Dana Buzoianu, Giuseppe Valacchi. Cytokines Genotype‐Phenotype Correlation in Nonalcoholic Steatohepatitis. Oxidative Medicine and Cellular Longevity 2017; 2017(1) doi: 10.1155/2017/4297206
69
Yun Qiu, Sufan Wang, Ting Wan, Mingtong Ye, Rui Jiang, Lei Pei, Lili Yang. Blood-Based Novel Biomarkers for Nonalcoholic Steatohepatitis. Biomarkers in Medicine 2018; 12(5): 501 doi: 10.2217/bmm-2017-0361
70
Mirella Pastore, Alessandra Gentilini, Fabio Marra. Non-Alcoholic Fatty Liver Disease. 2020; : 97 doi: 10.1007/978-3-319-95828-6_6
71
Chieh Chen. The role of adipokines in the disease of metabolic-associated fatty liver disease. Tungs' Medical Journal 2023; 17(2): 49 doi: 10.4103/ETMJ.ETMJ-D-23-00015
72
Young Hwan Jang, Dong Hyun In, Jae Kook Yang, Hyuk Jin Moon, Gyu Tae Yoon, Ah Jeong Ryu, Yeo Joo Kim, Eun Young Lee, Hyun Jin Kim, Bon Jeong Ku, Jae Min Lee, Kang Seo Park, In Suk Lee, Jong Min Lee, Dong Mee Lim, Keun Yong Park, Sang Jin Kim. The Effect of Vildagliptin on Visfatin in Korean Patients with Type 2 Diabetes: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Prospective Study. The Journal of Korean Diabetes 2015; 16(4): 303 doi: 10.4093/jkd.2015.16.4.303
73
Ludovico Abenavoli, Natasa Milic, Laura Di Renzo, Tomislav Preveden, Milica Medić-Stojanoska, Antonino De Lorenzo. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(31): 7006-7016 doi: 10.3748/wjg.v22.i31.7006
74
Yu-Lin Chao, Pei-Yu Wu, Jiun-Chi Huang, Yi-Wen Chiu, Jia-Jung Lee, Szu-Chia Chen, Jer-Ming Chang, Shang-Jyh Hwang, Hung-Chun Chen. Hepatic Steatosis Is Associated with High White Blood Cell and Platelet Counts. Biomedicines 2022; 10(4): 892 doi: 10.3390/biomedicines10040892
75
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic review. Obesity Reviews 2019; 20(7): 1057 doi: 10.1111/obr.12853
76
Carmelo Luci, Elodie Vieira, Thibaut Perchet, Philippe Gual, Rachel Golub. Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01192
77
Wen Liu, Fuxiang Bai, Hongxing Wang, Yan Liang, Xianhong Du, Cui Liu, Dejian Cai, Jiali Peng, Guangming Zhong, Xiaohong Liang, Chunhong Ma, Lifen Gao. Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in Macrophages. The Journal of Immunology 2019; 203(4): 990 doi: 10.4049/jimmunol.1900117
78
Monica Dinu, Anne Whittaker, Giuditta Pagliai, Ilaria Giangrandi, Barbara Colombini, Anna Maria Gori, Claudia Fiorillo, Matteo Becatti, Alessandro Casini, Stefano Benedettelli, Francesco Sofi. A Khorasan Wheat-Based Replacement Diet Improves Risk Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD): A Randomized Clinical Trial. Journal of the American College of Nutrition 2018; 37(6): 508 doi: 10.1080/07315724.2018.1445047
79
Shunqin Wang, Jingsong Liu, Junfeng Zhang, Jiancheng Lin, Shuyu Yang, Jiangwu Yao, Minquan Du. Glycemic control and adipokines after periodontal therapy in patients with Type 2 diabetes and chronic periodontitis. Brazilian Oral Research 2017; 31(0) doi: 10.1590/1807-3107bor-2017.vol31.0090
80
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Sung Mun Bae, Hyun Pil Yang, Eun-Kyung Kim. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(11): 2586 doi: 10.3390/nu11112586
81
Emilio Molina‐Molina, Guilherme Eustaquio. Furtado, John G. Jones, Piero Portincasa, Ana Vieira‐Pedrosa, Ana Maria Teixeira, Marcelo Paes Barros, André Luís Lacerda Bachi, Vilma A. Sardão. The advantages of physical exercise as a preventive strategy against NAFLD in postmenopausal women. European Journal of Clinical Investigation 2022; 52(3) doi: 10.1111/eci.13731
82
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
83
Jari E. Kaikkonen, Petri Kresanov, Markku Ahotupa, Antti Jula, Vera Mikkilä, Jorma S. A. Viikari, Markus Juonala, Nina Hutri-Kähönen, Mika Kähönen, Terho Lehtimäki, Antti J. Kangas, Pasi Soininen, Mika Ala-Korpela, Olli T. Raitakari. Longitudinal study of circulating oxidized LDL and HDL and fatty liver: the Cardiovascular Risk in Young Finns Study. Free Radical Research 2016; 50(4): 396 doi: 10.3109/10715762.2015.1133906
84
Roya Navekar, Maryam Rafraf, Aida Ghaffari, Mohammad Asghari-Jafarabadi, Manouchehr Khoshbaten. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases. Journal of the American College of Nutrition 2017; 36(4): 261 doi: 10.1080/07315724.2016.1267597
85
Johannes Sollner. Vaccine Design. Methods in Molecular Biology 2016; 1403: 107 doi: 10.1007/978-1-4939-3387-7_5
86
The effect of complex treatment of patients with non-alcoholic steatohepatitis in combination with type 2 diabetes on the course of the inflammatory process: adiponectin and proinflammatory cytokines. Family medicine 2018; (3): 53 doi: 10.30841/2307-5112.3.2018.146359
87
V.B. Yagmur, L.V. Demeshkina, S.L. Melanich, R.M. Kyslova. Influence of age, body mass index and gender on sonographic indicators of the liver in patients with metabolic dysfunction-associated steatotic liver disease. GASTROENTEROLOGY 2024; 58(2): 114 doi: 10.22141/2308-2097.58.2.2024.604
88
Noha F. Hassan, Somaia A. Nada, Azza Hassan, Mona R. El-Ansary, Muhammad Y. Al-Shorbagy, Rania M. Abdelsalam. Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis. Inflammation 2019; 42(3): 1056 doi: 10.1007/s10753-019-00967-6
89
Sara Parrettini, Massimiliano Cavallo, Francesco Gaggia, Riccardo Calafiore, Giovanni Luca. Adipokines: A Rainbow of Proteins with Metabolic and Endocrine Functions. Protein & Peptide Letters 2020; 27(12): 1204 doi: 10.2174/0929866527666200505214555
90
Yuling Xing, Jinhu Chen, Jing Liu, Guangyao Song, Huijuan Ma. Relationship Between Serum Uric Acid-to-Creatinine Ratio and the Risk of Metabolic-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 257 doi: 10.2147/DMSO.S350468
91
H Hen, Y Tang, L Zhuang, Y Zheng, X Huang. PINK1/Park2-Mediated Mitophagy Relieve Non-Alcoholic Fatty Liver Disease. Physiological Research 2024; : 253 doi: 10.33549/physiolres.934925
92
Qian Wang, Dehai Li, Jing Zhu, Mingyue Zhang, Hua Zhang, Guangchao Cao, Leqing Zhu, Qiping Shi, Jianlei Hao, Qiong Wen, Zonghua Liu, Hengwen Yang, Zhinan Yin. Perforin Acts as an Immune Regulator to Prevent the Progression of NAFLD. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00846
93
Kun Tang, Fei Wang, Yi Zeng, XueMeng Chen, XiaoLe Xu. Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient mice. European Journal of Pharmacology 2018; 830: 76 doi: 10.1016/j.ejphar.2018.04.026
94
Petra Surlin, Andreea Cristiana Didilescu, Luminita Lazar, Cristian Cosmin Arsenie, Adrian Camen, Dora Maria Popescu, Dorin Nicolae Gheorghe, Eugen Osiac, Ion Rogoveanu. Evaluation Through the Optical Coherence Tomography Analysis of the Influence of Non-Alcoholic Fatty Liver Disease on the Gingival Inflammation in Periodontal Patients. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 2935 doi: 10.2147/DMSO.S310314
95
Md Monirujjaman, Oliver F. Bathe, Vera C. Mazurak. Dietary EPA+DHA Mitigate Hepatic Toxicity and Modify the Oxylipin Profile in an Animal Model of Colorectal Cancer Treated with Chemotherapy. Cancers 2022; 14(22): 5703 doi: 10.3390/cancers14225703
96
Rozita Khodashahi, Mohsen Aliakbarian, Gordon A Ferns, Mohammad-Hassan Arjmand. The Association between Circulating Adipocytokine Omentin Levels and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Current Molecular Medicine 2024; 24(11): 1374 doi: 10.2174/1566524023666230913105910
97
Wen-Chung Huang, Po-Chen Liao, Chun-Hsun Huang, Sindy Hu, Shih-Chun Huang, Shu-Ju Wu. Osthole attenuates lipid accumulation, regulates the expression of inflammatory mediators, and increases antioxidants in FL83B cells. Biomedicine & Pharmacotherapy 2017; 91: 78 doi: 10.1016/j.biopha.2017.04.051
98
Lauren Barron, Cathleen Courtney, James Bao, Emily Onufer, Roheena Z. Panni, Bola Aladegbami, Brad W. Warner. Intestinal resection-associated metabolic syndrome. Journal of Pediatric Surgery 2018; 53(6): 1142 doi: 10.1016/j.jpedsurg.2018.02.077
99
Panagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis. Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations. World Journal of Gastroenterology 2022; 28(39): 5691-5706 doi: 10.3748/wjg.v28.i39.5691
100
Evelyn Nunes Goulart da Silva Pereira, Beatriz Peres de Araujo, Karine Lino Rodrigues, Raquel Rangel Silvares, Carolina Souza Machado Martins, Edgar Eduardo Ilaquita Flores, Caroline Fernandes-Santos, Anissa Daliry. Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress. Nutrients 2022; 14(3): 716 doi: 10.3390/nu14030716
101
Hon-Jhe Chen, Hao-Yu Yang, Kuang-Chieh Hsueh, Cheng-Che Shen, Ru-Yi Chen, Hsien-Chung Yu, Tzu-Lin Wang. Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease. Medicine 2018; 97(42): e12835 doi: 10.1097/MD.0000000000012835
102
Lili Chen, Xiaolong Zhao, Guangjun Liang, Jiuru Sun, Zhifeng Lin, Renming Hu, Peili Chen, Zhaoyun Zhang, Linuo Zhou, Yiming Li. Recombinant SFRP5 protein significantly alleviated intrahepatic inflammation of nonalcoholic steatohepatitis. Nutrition & Metabolism 2017; 14(1) doi: 10.1186/s12986-017-0208-0
103
Ahad Eshraghian, Saman Nikeghbalian, Bita Geramizadeh, Seyed Ali Malek-Hosseini. Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis. United European Gastroenterology Journal 2018; 6(1): 97 doi: 10.1177/2050640617707863
104
Montgomery Blencowe, Tilan Karunanayake, Julian Wier, Neil Hsu, Xia Yang. Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver Disease. Genes 2019; 10(12): 966 doi: 10.3390/genes10120966
105
Alice Yuxin Wang, Jasbir Dhaliwal, Marialena Mouzaki. Lean non-alcoholic fatty liver disease. Clinical Nutrition 2019; 38(3): 975 doi: 10.1016/j.clnu.2018.08.008
106
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros. Adipokines in nonalcoholic fatty liver disease. Metabolism 2016; 65(8): 1062 doi: 10.1016/j.metabol.2015.11.006
107
Sangam Rajak. Dynamics of cellular plasticity in non-alcoholic steatohepatitis (NASH). Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(4): 167102 doi: 10.1016/j.bbadis.2024.167102
108
Maja Cigrovski Berkovic, Lucija Virovic-Jukic, Ines Bilic-Curcic, Anna Mrzljak. Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management. World Journal of Gastroenterology 2020; 26(21): 2740-2757 doi: 10.3748/wjg.v26.i21.2740
109
Shusong Wu, Ruizhi Hu, Hironobu Nakano, Keyu Chen, Ming Liu, Xi He, Hongfu Zhang, Jianhua He, De-Xing Hou. Modulation of Gut Microbiota by Lonicera caerulea L. Berry Polyphenols in a Mouse Model of Fatty Liver Induced by High Fat Diet. Molecules 2018; 23(12): 3213 doi: 10.3390/molecules23123213
110
Teresa Auguet, Laia Bertran, Jessica Binetti, Carmen Aguilar, Salomé Martínez, Fàtima Sabench, Jesús Miguel Lopez-Dupla, José Antonio Porras, David Riesco, Daniel Del Castillo, Cristóbal Richart. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2020; 21(11): 4189 doi: 10.3390/ijms21114189
111
Jinjin Li, Jialin Li, Jiajia Ni, Caibo Zhang, Jianlei Jia, Guoying Wu, Hongzhao Sun, Shuzhen Wang. Berberine Relieves Metabolic Syndrome in Mice by Inhibiting Liver Inflammation Caused by a High-Fat Diet and Potential Association With Gut Microbiota. Frontiers in Microbiology 2022; 12 doi: 10.3389/fmicb.2021.752512
112
Youzhao Jiang, Liu Chen, Hui Wang, Bao Narisi, Bing Chen. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress. Journal of Ethnopharmacology 2015; 176: 499 doi: 10.1016/j.jep.2015.11.019
113
Milton Packer. Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction in Patients With Nonalcoholic Fatty Liver Disease. The American Journal of Medicine 2020; 133(2): 170 doi: 10.1016/j.amjmed.2019.09.002
114
Krasimira Aleksandrova, Sabrina Schlesinger, Marta Stelmach-Mardas. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 755 doi: 10.1007/978-94-007-7675-3_37
115
Shankun Zhao, Yaoyao Wang, Weizhou Wu, Suqing Yang, Lili Feng, Fangfang Tao, Weiwei Ge, Maolei Shen, Weifang Xu. Nonalcoholic fatty liver disease and risk of prostatic diseases: Roles of insulin resistance. Andrologia 2021; 53(6) doi: 10.1111/and.14060
116
Magdalena Świderska, Mateusz Maciejczyk, Anna Zalewska, Joanna Pogorzelska, Robert Flisiak, Adrian Chabowski. Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients. Free Radical Research 2019; 53(8): 841 doi: 10.1080/10715762.2019.1635691
117
S. A. Pavlovskyi. EVALUATION OF CONTENT OF CITOKINS IN PATIENTS� BLOOD WITH NON-ALCOHOLIC STEATOHEPATITIS COMBINED WITH DIABETES MELLITUS TYPE 2 UNDER THE INFLUENCE OF COMBINED SUCTIONAL THERAPY. Bulletin of Problems Biology and Medicine 2018; (144): 170 doi: 10.29254/2077-4214-2018-1-2-143-170-175
118
Yilizere Aibaidula, Mutalifu Aimaiti, Huiwen Tan, Bingting Chen, Jian Yang, Xiaoli Ma. Lactucin & Lactucopicrin ameliorates FFA-induced steatosis in HepG2 cells via modulating lipid metabolism. Journal of Pharmacological Sciences 2022; 150(2): 110 doi: 10.1016/j.jphs.2022.07.007
119
Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Eugeniusz Tarasów, Małgorzata Wojtkowska, Irena Białokoz-Kalinowska, Dariusz Marek Lebensztejn. Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/3870454
120
R.B. Prussick, L. Miele. Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?. British Journal of Dermatology 2018; 179(1): 16 doi: 10.1111/bjd.16239
121
Song Wang, Jian Wang, Yajing Liu, Hui Li, Qiao Wang, Zhiwei Huang, Wenbin Liu, Ping Shi. Trivalent Chromium Supplementation Ameliorates Oleic Acid-Induced Hepatic Steatosis in Mice. Biological Trace Element Research 2019; 187(1): 192 doi: 10.1007/s12011-018-1368-0
122
Badamgarav Bat-Erdene, Min He, Jingsong Dong, Ying Li, Dean Ta. Therapeutic Effects of Different Ultrasound Intensity Stimulation on Brown Adipose Tissue for the Treatment of Type 2 Diabetes. Ultrasound in Medicine & Biology 2025;  doi: 10.1016/j.ultrasmedbio.2025.01.010
123
A Al-Radaideh, R Tayyem, K Al-Fayomi, N Nimer, A Almomani, S Alhajjaj, L Agraib, N Hijjawi. The association of hepatic fat percentage with selected anthropometric and biochemical parameters at 3-Tesla magnetic resonance imaging. British Journal of Biomedical Science 2019; 76(2): 70 doi: 10.1080/09674845.2019.1571555
124
Mooli Raja Gopal Reddy, Malleswarapu Mahesh, Munikumar Manne, Uday Kumar Putcha, Shanmugam M. Jeyakumar. Vitamin A and its metabolic pathway play a determinant role in high‐fructose‐induced triglyceride accumulation of the visceral adipose depot of male Wistar rats. Cell Biochemistry and Function 2019; 37(8): 578 doi: 10.1002/cbf.3434
125
Mitra Ahadi, Kasra Molooghi, Negin Masoudifar, Ali Beheshti Namdar, Hassan Vossoughinia, Mohammadreza Farzanehfar. A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals. Journal of Gastroenterology and Hepatology 2021; 36(6): 1497 doi: 10.1111/jgh.15353
126
María Gordito Soler, Ángel Arturo López-González, Daniela Vallejos, Emilio Martínez-Almoyna Rifá, María Teófila Vicente-Herrero, José Ignacio Ramírez-Manent. Usefulness of Body Fat and Visceral Fat Determined by Bioimpedanciometry versus Body Mass Index and Waist Circumference in Predicting Elevated Values of Different Risk Scales for Non-Alcoholic Fatty Liver Disease. Nutrients 2024; 16(13): 2160 doi: 10.3390/nu16132160
127
Ru Xun Foo, Jenny Junyi Ma, Ruochen Du, George Boon Bee Goh, Yap Seng Chong, Cuilin Zhang, Ling-Jun Li. Gestational diabetes mellitus and development of intergenerational non-alcoholic fatty liver disease (NAFLD) after delivery: a systematic review and meta-analysis. eClinicalMedicine 2024; 72: 102609 doi: 10.1016/j.eclinm.2024.102609
128
Emma Rose McGlone, Ahmed R. Ahmed. Global Bariatric Surgery. 2018; : 403 doi: 10.1007/978-3-319-93545-4_36
129
Hui Li, Mark J. Canet, John D. Clarke, Dean Billheimer, Stavra A. Xanthakos, Joel E. Lavine, Robert P. Erickson, Nathan J. Cherrington. Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis. Drug Metabolism and Disposition 2017; 45(12): 1317 doi: 10.1124/dmd.117.077644
130
George N. Dalekos, Nikolaos K. Gatselis, Kalliopi Zachou, George K. Koukoulis. NAFLD and autoimmune hepatitis: Do not judge a book by its cover. European Journal of Internal Medicine 2020; 75: 1 doi: 10.1016/j.ejim.2020.02.001
131
Sumit Kar, Sabina Paglialunga, Sharon H. Jaycox, Rafiqul Islam, Angelo H. Paredes, Rohit Kohli. Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis. PLOS ONE 2019; 14(7): e0217263 doi: 10.1371/journal.pone.0217263
132
Johanna Heitmann, Verena G. Frings, Andreas Geier, Matthias Goebeler, Andreas Kerstan. Non‐alcoholic fatty liver disease and psoriasis – is there a shared proinflammatory network?. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2021; 19(4): 517 doi: 10.1111/ddg.14425
133
Susana Castro-Sánchez, Esteban Pérez-Giraldo, Juan Carlos Restrepo-Gutiérrez, Carlos E. Builes-Montaño. Enfermedad hepática grasa no alcohólica en personas no obesas: revisión narrativa de la literatura. Hepatología 2021; : 223 doi: 10.52784/27112330.129
134
Narges Damavandi, Sirous Zeinali. Association of xenobiotic-metabolizing enzymes (GSTM1 and GSTT 1), and pro-inflammatory cytokines (TNF-α and IL-6) genetic polymorphisms with non-alcoholic fatty liver disease. Molecular Biology Reports 2021; 48(2): 1225 doi: 10.1007/s11033-021-06142-1
135
Nadia Panera, Claudia Della Corte, Annalisa Crudele, Laura Stronati, Valerio Nobili, Anna Alisi. Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines. Expert Review of Gastroenterology & Hepatology 2016; 10(3): 393 doi: 10.1586/17474124.2016.1110485
136
Sifan Chen, Zhongliang Zhao, Liangru Ke, Zilun Li, Wenxue Li, Zili Zhang, Ying Zhou, Xiang Feng, Wei Zhu. Resveratrol improves glucose uptake in insulin-resistant adipocytes via Sirt1. The Journal of Nutritional Biochemistry 2018; 55: 209 doi: 10.1016/j.jnutbio.2018.02.007
137
Marko Duvnjak, Sanja Stojsavljević, Lucija Virović Jukić, Lea Smirčić Duvnjak. Risk Factors for Colorectal Adenoma – Acknowledging the Burden of NAFLD. Journal of Clinical and Translational Hepatology 2019; 7(2): 97 doi: 10.14218/JCTH.2019.00022
138
Simona Cernea, Andrada Larisa Roiban, Emőke Both, Adina Huţanu. Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews 2018; 34(8) doi: 10.1002/dmrr.3050
139
Claudia Calder�n‑Torres, Lirio Sarabia‑Curz, Yadira Ledesma‑Soto, Miguel Murgu�a‑Romero, Luis Terrazas‑Vald�s. Denitrase activity of Debaryomyces�hansenii reduces the oxidized compound 3‑nitrotyrosine in mice liver with colitis. Experimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7395
140
Qiwen Pang, Zhen Sun, Chen Shao, Honghua Cai, Zhengyang Bao, Lin Wang, Lihua Li, Lele Jing, Lili Zhang, Zhongqun Wang. CML/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty Liver. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.583943
141
Rohith N. Thota, Jessica J. A. Ferguson, Kylie A. Abbott, Cintia B. Dias, Manohar L. Garg. Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: biochemical effectsvs. clinical outcomes. Food & Function 2018; 9(7): 3576 doi: 10.1039/C8FO00348C
142
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova, Minara Sh. Shamkhalova. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv 2022; 94(2): 216 doi: 10.26442/00403660.2022.02.201363
143
Doaa El Amrousy, Dalia El-Afify. Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease. Cytokine 2020; 135: 155215 doi: 10.1016/j.cyto.2020.155215
144
Stavroula Kanoni, Satish Kumar, Charalampia Amerikanou, Mary Jo Kurth, Maria G. Stathopoulou, Stephane Bourgeois, Christine Masson, Aimo Kannt, Lucia Cesarini, Maria-Spyridoula Kontoe, Maja Milanović, Francisco J. Roig, Mirjana Beribaka, Jonica Campolo, Nuria Jiménez-Hernández, Nataša Milošević, Carlos Llorens, Ilias Smyrnioudis, M. Pilar Francino, Nataša Milić, Andriana C. Kaliora, Maria Giovanna Trivella, Mark W. Ruddock, Milica Medić-Stojanoska, Amalia Gastaldelli, John Lamont, Panos Deloukas, George V. Dedoussis, Sophie Visvikis-Siest. Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.683028
145
Hong Yao, Yu-Jie Qiao, Ya-Li Zhao, Xu-Feng Tao, Li-Na Xu, Lian-Hong Yin, Yan Qi, Jin-Yong Peng. Herbal medicines and nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(30): 6890-6905 doi: 10.3748/wjg.v22.i30.6890
146
Shadi Nouri, Mahsa Navari, Fatemeh Zarei, Mitra Rostami, Touraj Mahmoudi, Gholamreza Rezamand, Asadollah Asadi, Hossein Nobakht, Reza Dabiri, Seidamir Pasha Tabaeian. NAMPT gene rs2058539 variant is a risk factor for nonalcoholic fatty liver disease. Revista da Associação Médica Brasileira 2024; 70(7) doi: 10.1590/1806-9282.20230188
147
Jiawei Huang, Rumeng Jiang, Yonghong Wang. Effects of the probioticBacillus coagulansBC69 on the metabolic and histological alterations induced by a high-sugar and high-fat diet in C57BL/6J mice. Food & Function 2023; 14(14): 6596 doi: 10.1039/D3FO01104F
148
Qian Zhang, Kun Yu, Yazhen Cao, Yanli Luo, Yan Liu, Caiyan Zhao. miR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3. Life Sciences 2021; 270: 119071 doi: 10.1016/j.lfs.2021.119071
149
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
150
Madeleine Themanns, Kristina M. Mueller, Sonja M. Kessler, Nicole Golob-Schwarzl, Thomas Mohr, Doris Kaltenecker, Jerome Bourgeais, Jamile Paier-Pourani, Katrin Friedbichler, Doris Schneller, Michaela Schlederer, Eva Zebedin-Brandl, Luigi M. Terracciano, Xiaonan Han, Lukas Kenner, Kay-Uwe Wagner, Wolfgang Mikulits, Andrey V. Kozlov, Markus H. Heim, Fabrice Gouilleux, Johannes Haybaeck, Richard Moriggl. Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in Mice. Scientific Reports 2016; 6(1) doi: 10.1038/srep34719
151
Jennifer C Price, Ruibin Wang, Eric C Seaberg, Matthew J Budoff, Lawrence A Kingsley, Frank J Palella , Mallory D Witt, Wendy S Post, Chloe L Thio. The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus. Open Forum Infectious Diseases 2017; 4(3) doi: 10.1093/ofid/ofx153
152
Divyavani Gowda, Chandra Shekhar, Siddabasave Gowda B. Gowda, Yifan Chen, Shu-Ping Hui. Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease. Livers 2023; 3(4): 687 doi: 10.3390/livers3040045
153
Frédéric Hérault, Magalie Houée-Bigot, Elisabeth Baéza, Olivier Bouchez, Diane Esquerré, Christophe Klopp, Christian Diot. RNA-seq analysis of hepatic gene expression of common Pekin, Muscovy, mule and hinny ducks fed ad libitum or overfed. BMC Genomics 2019; 20(1) doi: 10.1186/s12864-018-5415-1
154
Pervej Alom Barbhuiya, Ameena Ahmed, Partha Pratim Dutta, Saikat Sen, Manash Pratim Pathak. Mitigating Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Role of Bioactive Phytoconstituents in Indian Culinary Spices. Current Nutrition Reports 2025; 14(1) doi: 10.1007/s13668-024-00598-w
155
Kasra Pirahesh, Ali Zarrinnia, Leila Nikniaz, Zeinab Nikniaz. Association between sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Preventive Medicine Reports 2025; 50: 102968 doi: 10.1016/j.pmedr.2025.102968
156
Andriana C. Kaliora, Aristea Gioxari, Ioanna Panagiota Kalafati, Anastasia Diolintzi, Alexandros Kokkinos, George V. Dedoussis. The Effectiveness of Mediterranean Diet in Nonalcoholic Fatty Liver Disease Clinical Course: An Intervention Study. Journal of Medicinal Food 2019; 22(7): 729 doi: 10.1089/jmf.2018.0020
157
Tharani Senavirathna, Armaghan Shafaei, Ricky Lareu, Lois Balmer. Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Antioxidants 2024; 13(4): 485 doi: 10.3390/antiox13040485
158
Gökay Taylan, Mustafa Ebik, Serdar Solak, Çağlar Kaya, Kenan Yalta. Risk of premature coronary atherosclerosis in patients with nonalcoholic fatty liver disease. Revista da Associação Médica Brasileira 2022; 68(10): 1428 doi: 10.1590/1806-9282.20220514
159
Bin Liu, Liping Xiang, Jing Ji, Wei Liu, Ying Chen, Mingfeng Xia, Yuejun Liu, Wenyue Liu, Peiwu Zhu, Yi Jin, Yu Han, Jieli Lu, Xiaoying Li, Minghua Zheng, Yan Lu. Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2. Journal of Clinical Investigation 2021; 131(20) doi: 10.1172/JCI144801
160
Agnieszka Zwolak, Agnieszka Szuster-Ciesielska, Jadwiga Daniluk, Olga Słabczyńska, Martyna Kandefer-Szerszeń, Patricia Aspichueta. Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate. PLOS ONE 2015; 10(12): e0143851 doi: 10.1371/journal.pone.0143851
161
Ying-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, Chao-Feng Chang, Chi-Wei Yang, Wu-Chien Chien, Yi-Chiao Cheng. Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study. Intestinal Research 2025; 23(1): 76 doi: 10.5217/ir.2023.00078
162
Keke Lu, Jing Wang, Yueyuan Yu, Yikuan Wu, Zhao He. Lycium ruthenicum Murr. alleviates nonalcoholic fatty liver in mice. Food Science & Nutrition 2020; 8(6): 2588 doi: 10.1002/fsn3.1445
163
Emily J. Onufer, Yong-Hyun Han, Cathleen Courtney, Allie Steinberger, Maria Tecos, Stephanie Sutton, Anne Sescleifer, Jocelyn Ou, Rafael Sanguinetti Czepielewski, Gwendalyn J. Randolph, Brad W. Warner. Liver injury after small bowel resection is prevented in obesity-resistant 129S1/SvImJ mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(5): G907 doi: 10.1152/ajpgi.00284.2020
164
Fabio Salvatore Macaluso, Marcello Maida, Salvatore Petta. Genetic background in nonalcoholic fatty liver disease: A comprehensive review. World Journal of Gastroenterology 2015; 21(39): 11088-11111 doi: 10.3748/wjg.v21.i39.11088
165
Zhihong Ma, Li Chu, Hongying Liu, Jieru Li, Yuanyuan Zhang, Wentai Liu, Jun Dai, Jianfeng Yi, Yue Gao. Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: Involvement with the ROCK/NF-κB pathway. International Immunopharmacology 2016; 38: 377 doi: 10.1016/j.intimp.2016.06.023
166
Cara Mack, Shikha S. Sundaram. Pediatric Gastrointestinal and Liver Disease. 2021; : 804 doi: 10.1016/B978-0-323-67293-1.00073-6
167
Marwan SM Al-Nimer. Is COVID-19-induced liver injury different from other RNA viruses?‎. World Journal of Meta-Analysis 2021; 9(2): 108-127 doi: 10.13105/wjma.v9.i2.108
168
Helena A.P. Batatinha, Edson A. Lima, Alexandre A.S. Teixeira, Camila O. Souza, Luana A. Biondo, Loreana S. Silveira, Fabio S. Lira, José C. Rosa Neto. Association Between Aerobic Exercise and Rosiglitazone Avoided the NAFLD and Liver Inflammation Exacerbated in PPAR‐α Knockout Mice. Journal of Cellular Physiology 2017; 232(5): 1008 doi: 10.1002/jcp.25440
169
Natalia Muñoz-Durango, Marco Arrese, Alejandra Hernández, Evelyn Jara, Alexis M. Kalergis, Daniel Cabrera. A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8+ T Cells in a Nonalcoholic Steatohepatitis Mouse Model. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.563434
170
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins & Other Lipid Mediators 2023; 169: 106766 doi: 10.1016/j.prostaglandins.2023.106766
171
Mei-Jou Chen, Hong-Nerng Ho. Hepatic manifestations of women with polycystic ovary syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology 2016; 37: 119 doi: 10.1016/j.bpobgyn.2016.03.003
172
Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova, Milena Peruhova, Georgi H. Vasilev, Georgi V. Vasilev, Metodija Sekulovski, Snezhina Lazova, Milena Gulinac, Latchezar Tomov, Antoaneta Mihova, Tsvetelina Velikova. Microbiome and Genetic Factors in the Pathogenesis of Liver Diseases. Gastroenterology Insights 2023; 14(4): 575 doi: 10.3390/gastroent14040041
173
Shuangpeng Cai, Xiaoyu Cheng, Xueyin Pan, Jun Li. Emerging role of exosomes in liver physiology and pathology. Hepatology Research 2017; 47(2): 194 doi: 10.1111/hepr.12794
174
Yaping Wang, Xiaobo Li, Shunlin Ren. Cholesterol Metabolites 25-Hydroxycholesterol and 25-Hydroxycholesterol 3-Sulfate Are Potent Paired Regulators: From Discovery to Clinical Usage. Metabolites 2020; 11(1): 9 doi: 10.3390/metabo11010009
175
Jae B. Park, Renee Peters, Quynhchi Pham, Thomas T. Y. Wang. Javamide-II Inhibits IL-6 without Significant Impact on TNF-alpha and IL-1beta in Macrophage-Like Cells. Biomedicines 2020; 8(6): 138 doi: 10.3390/biomedicines8060138
176
Ana Ninić, Marija Zdravković, Vojislav Radosavljević, Vera Gardijan, Lidija Memon, Jelena Vekić, Vesna Spasojević-Kalimanovska. Non-alcoholic fatty liver disease as metabolic consequence of obstructive sleep apnea. Arhiv za farmaciju 2020; 70(6): 319 doi: 10.5937/arhfarm70-27586
177
K.K. Gao, F.-H. Li, Y.-M. Su, J. Wang, X.-M. Yu, L. Ruan, Y.-Z. Zhang. Impact of exercise intervention-based remote monitoring for patients with different grades of non-alcoholic fatty liver disease severity. Science & Sports 2024; 39(1): 62 doi: 10.1016/j.scispo.2022.10.007
178
V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(4): 104 doi: 10.22416/1382-4376-2022-32-4-104-140
179
T.S. Sall, E.S. Shcherbakova, S.I. Sitkin, T.Ya. Vakhitov, I.G. Bakulin, E.V. Demyanova. Molecular mechanisms of non-alcoholic fatty liver disease development. Profilakticheskaya meditsina 2021; 24(4): 120 doi: 10.17116/profmed202124041120
180
Aldona Kasprzak, Agnieszka Adamek. Role of the Ghrelin System in Colitis and Hepatitis as Risk Factors for Inflammatory-Related Cancers. International Journal of Molecular Sciences 2022; 23(19): 11188 doi: 10.3390/ijms231911188
181
J. E. Nelson, P. Handa, B. Aouizerat, L. Wilson, L. A. Vemulakonda, M. M. Yeh, K. V. Kowdley. Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms. Alimentary Pharmacology & Therapeutics 2016; 44(11-12): 1253 doi: 10.1111/apt.13824
182
Rocío Aller, Beatriz Burgueño Gomez, Rebeca Sigüenza, Conrado Fernández-Rodríguez, Natalia Fernández, Beatriz Antolín, Miguel Dur�, María Pina, Sara Lorenzo, Concepción García, Daniel de Luis Román. Comparative study of overweight and obese patients with nonalcoholic fatty liver disease. Revista Española de Enfermedades Digestivas 2019;  doi: 10.17235/reed.2019.5926/2018
183
Tamara Bassal, Maamoun Basheer, Mariana Boulos, Nimer Assy. Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers. Metabolites 2022; 12(11): 1073 doi: 10.3390/metabo12111073
184
Dominik Wupperfeld, Gert Fricker, Béatrice Bois De Fer, Branko Popovic. Essential phospholipids impact cytokine secretion and alter lipid-metabolizing enzymes in human hepatocyte cell lines. Pharmacological Reports 2024; 76(3): 572 doi: 10.1007/s43440-024-00595-4
185
Jie Wei, Yong-Zhan Zhen, Ju Cui, Fa-Lin He, Tao Shen, Gang Hu, Xiao-Hong Ren, Ya-Jun Lin. Rhein lysinate decreases inflammation and adipose infiltration in KK/HlJ diabetic mice with non-alcoholic fatty liver disease. Archives of Pharmacal Research 2016; 39(7): 960 doi: 10.1007/s12272-016-0770-4
186
Xin Hou, Shi Yin, Ruixue Ren, Siqi Liu, Liang Yong, Yuxiao Liu, Yu Li, Ming‐Hua Zheng, George Kunos, Bin Gao, Hua Wang. Myeloid‐Cell–Specific IL‐6 Signaling Promotes MicroRNA‐223‐Enriched Exosome Production to Attenuate NAFLD‐Associated Fibrosis. Hepatology 2021; 74(1): 116 doi: 10.1002/hep.31658
187
Jennifer C Price, Yifei Ma, Mark H Kuniholm, Adaora A Adimora, Margaret Fischl, Audrey L French, Elizabeth T Golub, Deborah Konkle-Parker, Howard Minkoff, Ighovwerha Ofotokun, Michael Plankey, Anjali Sharma, Phyllis C Tien. Human Immunodeficiency Virus Is Associated With Elevated FibroScan–Aspartate Aminotransferase (FAST) Score. Clinical Infectious Diseases 2022; 75(12): 2119 doi: 10.1093/cid/ciac337
188
Christa Buechler, Elisabeth Haberl, Lisa Rein-Fischboeck, Charalampos Aslanidis. Adipokines in Liver Cirrhosis. International Journal of Molecular Sciences 2017; 18(7): 1392 doi: 10.3390/ijms18071392
189
Florian G. Scurt, Maximilian J. Ganz, Carolin Herzog, Katrin Bose, Peter R. Mertens, Christos Chatzikyrkou. Association of metabolic syndrome and chronic kidney disease. Obesity Reviews 2024; 25(1) doi: 10.1111/obr.13649
190
Rafael Bergesch D’Incao, Cristiane Valle Tovo, Vanessa Suñé Mattevi, Diego Olschowsky Borges, Jane Maria Ulbrich, Gabriela Perdomo Coral, Mauricio Jacques Ramos, Nelson Guardiola Meinhardt. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients. Obesity Surgery 2017; 27(8): 2151 doi: 10.1007/s11695-017-2627-4
191
Pervej Alom Barbhuiya, Saikat Sen, Manash Pratim Pathak. Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review. Phytochemistry Reviews 2024; 23(4): 969 doi: 10.1007/s11101-023-09912-w
192
Samukelisiwe C. Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, Abidemi P. Kappo, Albertus K. Basson, Carmen Pheiffer, Rabia Johnson. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomedicine & Pharmacotherapy 2020; 131: 110785 doi: 10.1016/j.biopha.2020.110785
193
Huong Thi Nguyen, Mingkun Gu, Pia Werlinger, Joo-Hyung Cho, Jinhua Cheng, Joo-Won Suh. Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota. International Journal of Molecular Sciences 2022; 23(21): 13436 doi: 10.3390/ijms232113436
194
Wen Deng, Zimin Meng, Aitao Sun, Zhihong Yang. Pioglitazone suppresses inflammation and fibrosis in nonalcoholic fatty liver disease by down-regulating PDGF and TIMP-2: Evidence from in vitro study. Cancer Biomarkers 2017; 20(4): 411 doi: 10.3233/CBM-170157
195
Malleswarapu Mahesh, Munugala Bharathi, Mooli Raja Gopal Reddy, Pranati Pappu, Uday Kumar Putcha, Ayyalasomayajula Vajreswari, Shanmugam M Jeyakumar. Carrot juice ingestion attenuates high fructose‐induced circulatory pro‐inflammatory mediators in weanling Wistar rats. Journal of the Science of Food and Agriculture 2017; 97(5): 1582 doi: 10.1002/jsfa.7906
196
Bahareh Amirkalali, Masoud Reza Sohrabi, Ali Esrafily, Mahmoud Jalali, Ali Gholami, Payam Hosseinzadeh, Hossein Keyvani, Farzad Shidfar, Farhad Zamani. Erythrocyte membrane fatty acid profile & serum cytokine levels in patients with non-alcoholic fatty liver disease. Indian Journal of Medical Research 2018; 147(4): 352 doi: 10.4103/ijmr.IJMR_1065_16
197
Gopanandan Parthasarathy, Xavier Revelo, Harmeet Malhi. Pathogenesis of Nonalcoholic Steatohepatitis: An Overview. Hepatology Communications 2020; 4(4): 478 doi: 10.1002/hep4.1479
198
Jaqueline Pereira Lana, Laís Bhering Martins, Marina Chaves de Oliveira, Zélia Menezes-Garcia, Letícia Tamie Pavia Yamada, Leda Quercia Vieira, Mauro Martins Teixeira, Adaliene Versiani Matos Ferreira. TNF and IL-18 cytokines may regulate liver fat storage under homeostasis conditions. Applied Physiology, Nutrition, and Metabolism 2016; 41(12): 1295 doi: 10.1139/apnm-2016-0265
199
Aamir Bashir, Ajay Duseja, Arka De, Manu Mehta, Pramil Tiwari. Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena. Liver Research 2022; 6(2): 72 doi: 10.1016/j.livres.2022.05.002
200
Krasimira Aleksandrova, Sabrina Schlesinger, Marta Stelmach-Mardas. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_37-1
201
Li Xue, Xiaolan Lu, Juntao He, Ting Zhang, Xiaokang Wu, Yanping Zhang, Ningning Wang, Zhe An, Jiru Xu, Yan Geng. Serum CK 18-M30 reflect liver pathological severity during NAFLD progression in a rat model. Pathology - Research and Practice 2018; 214(11): 1778 doi: 10.1016/j.prp.2018.08.016
202
Vera Lede, Andrej Meusel, Antje Garten, Yulia Popkova, Melanie Penke, Christin Franke, Albert Ricken, Angela Schulz, Wieland Kiess, Daniel Huster, Torsten Schöneberg, Jürgen Schiller, Yanqiao Zhang. Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor. PLOS ONE 2017; 12(2): e0172000 doi: 10.1371/journal.pone.0172000
203
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
204
Nadella Mounika, Suraj Bhausaheb Mungase, Shivangi Verma, Savneet Kaur, Utpal Jyoti Deka, Tarini Shankar Ghosh, Ramu Adela. Inflammatory Protein Signatures as Predictive Disease-Specific Markers for Non-Alcoholic Steatohepatitis (NASH). Inflammation 2024; 48(1): 25 doi: 10.1007/s10753-024-02035-0
205
Krasimira Aleksandrova, Marta Stelmach-Mardas, Sabrina Schlesinger. Obesity and Cancer. Recent Results in Cancer Research 2016; 208: 177 doi: 10.1007/978-3-319-42542-9_10
206
Atul Goyale, Anjly Jain, Colette Smith, Margarita Papatheodoridi, Marta Guerrero Misas, Davide Roccarina, Laura Iogna Prat, Dimitri P. Mikhailidis, Devaki Nair, Emmanuel Tsochatzis, Pavel Strnad. Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study. PLOS ONE 2021; 16(11): e0260313 doi: 10.1371/journal.pone.0260313
207
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim. Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/7653689
208
Xu Zhang, Xuetao Ji, Qian Wang, John Zhong Li. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Protein & Cell 2018; 9(2): 164 doi: 10.1007/s13238-017-0436-0
209
Mohammad Shafi Kuchay, Narendra Singh Choudhary, Sunil Kumar Mishra. Pathophysiological mechanisms underlying MAFLD. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14(6): 1875 doi: 10.1016/j.dsx.2020.09.026
210
Ines Bilić-Ćurčić, Hrvoje Roguljić, Marul Ivandić, Aleksandar Včev, Robert Smolić, Martina Smolić. Update on Hepatitis C. 2017;  doi: 10.5772/intechopen.70721
211
Veeravich Jaruvongvanich, Anawin Sanguankeo, Tanawan Riangwiwat, Sikarin Upala. Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Annals of Hepatology 2017; 16(3): 382 doi: 10.5604/01.3001.0009.8593
212
Dongxu Wang, Qiang Gao, Taotao Wang, Zhipeng Kan, Xin Li, Lizhen Hu, Chuan-yi Peng, Frank Qian, Yijun Wang, Daniel Granato. Green tea polyphenols and epigallocatechin-3-gallate protect against perfluorodecanoic acid induced liver damage and inflammation in mice by inhibiting NLRP3 inflammasome activation. Food Research International 2020; 127: 108628 doi: 10.1016/j.foodres.2019.108628
213
Kui Peng, Lin Lin, Zhengyi Wang, Lin Ding, Ya Huang, Po Wang, Yu Xu, Jieli Lu, Min Xu, Yufang Bi, Weiqing Wang, Yuhong Chen, Guang Ning. Short sleep duration and longer daytime napping are associated with non‐alcoholic fatty liver disease in Chinese adults. Journal of Diabetes 2017; 9(9): 827 doi: 10.1111/1753-0407.12489
214
Paloma Gallego, Amparo Luque-Sierra, Gonzalo Falcon, Pilar Carbonero, Lourdes Grande, Juan D. Bautista, Franz Martín, José A. Del Campo. White Button Mushroom Extracts Modulate Hepatic Fibrosis Progression, Inflammation, and Oxidative Stress In Vitro and in LDLR-/- Mice. Foods 2021; 10(8): 1788 doi: 10.3390/foods10081788
215
Nitin Kapoor, Jennifer Audsley, Priscilla Rupali, Joe Sasadeusz, Thomas V. Paul, Nihal Thomas, Sharon R. Lewin. A gathering storm. AIDS 2019; 33(7): 1105 doi: 10.1097/QAD.0000000000002161
216
I. Rodriguez-Ramiro, D. Vauzour, A. M. Minihane. Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms. Proceedings of the Nutrition Society 2016; 75(1): 47 doi: 10.1017/S0029665115004218
217
Maria Jimenez Ramos, Lucia Bandiera, Filippo Menolascina, Jonathan Andrew Fallowfield. In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications. iScience 2022; 25(1): 103549 doi: 10.1016/j.isci.2021.103549
218
Mingjun Tan, Rami Mosaoa, Garrett T. Graham, Anna Kasprzyk-Pawelec, Shreyas Gadre, Erika Parasido, Olga Catalina-Rodriguez, Patricia Foley, Giuseppe Giaccone, Amrita Cheema, Bhaskar Kallakury, Chris Albanese, Chunling Yi, Maria Laura Avantaggiati. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. Cell Death & Differentiation 2020; 27(7): 2143 doi: 10.1038/s41418-020-0491-6
219
Ekrem Aksu, Abdullah Sokmen, Murat Ispiroglu, Kadir Gisi, Enes Celik, Ahmet Cagri Aykan. Early cardiac electrical and structural changes in patients with non-obese non-alcoholic fatty liver disease. Kardiologiia 2021; 61(5): 51 doi: 10.18087/cardio.2021.5.n1416
220
AhmedM M. Mahmouda, NohaA.-R A. El-Hagag, HusseinI El-Bitar, Abdel-HalimM Afifi. Potential protective effect of curcumin in high-fat diet-induced nonalcoholic fatty liver disease in rats. Journal of Current Medical Research and Practice 2021; 6(1): 92 doi: 10.4103/JCMRP.JCMRP_37_20
221
Sevket Balta. Atherosclerosis and Non-Alcoholic Fatty Liver Disease. Angiology 2022; 73(8): 701 doi: 10.1177/00033197221091317
222
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Tomomitsu Matono, Jun Kato, Shiho Tokunaga, Takaaki Sugihara, Akira Hiramatsu, Hideyuki Hyogo, Hiroshi Tobita, Shuichi Sato, Miwa Kawanaka, Yuichi Hara, Keisuke Hino, Kazuaki Chayama, Yoshikazu Murawaki, Hajime Isomoto, Catherine Mounier. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease. PLOS ONE 2020; 15(2): e0219412 doi: 10.1371/journal.pone.0219412
223
Mohamed M.A. Hussein, Hussein I. El-Belbasi, Mohamed A. Morsy, Islam M. Saadeldin, Ghedeir M. Alshammari. The synergistic effect of fenretinide and metformin to achieve a decrease in insulin resistance and inflammatory mediators: an in vivo study. All Life 2020; 13(1): 108 doi: 10.1080/26895293.2020.1732483
224
Nadia Panera, Barbara Barbaro, Claudia Della Corte, Antonella Mosca, Valerio Nobili, Anna Alisi. A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver disease. Nutrition Research 2018; 58: 1 doi: 10.1016/j.nutres.2018.05.002
225
M Pallavi, MM Suchitra, P.V.L.N Srinivasa Rao. Role of adipokines in the pathogenesis of nonalcoholic fatty liver disease. Journal of Clinical and Scientific Research 2015; 4(1): 31 doi: 10.15380/2277-5706.JCSR.14.072
226
Peter Müller, Marie Messmer, Monika Bayer, Josef M. Pfeilschifter, Edith Hintermann, Urs Christen. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model. Journal of Autoimmunity 2016; 69: 51 doi: 10.1016/j.jaut.2016.02.007
227
Min-Gyung Kang, Hee Jae Lee, Jae-Young Cho, Kanghwa Kim, Soo Jin Yang, Doman Kim. Anti-inflammatory effects of sucrose-derived oligosaccharides produced by a constitutive mutant L. mesenteroides B-512FMCM dextransucrase in high fat diet-fed mice. Biochemical and Biophysical Research Communications 2016; 477(3): 350 doi: 10.1016/j.bbrc.2016.06.102
228
Helda Tutunchi, Farideh Zolrahim, Mahlagha Nikbaf-Shandiz, Fatemeh Naeini, Alireza Ostadrahimi, Sina Naghshi, Reza Salek, Farzad Najafipour. Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trial. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1144550
229
Chen Shen, Jin Hong Chen, Ha Ram Oh, Ji Hyun Park. Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36. FEBS Letters 2021; 595(19): 2493 doi: 10.1002/1873-3468.14193
230
F. Hérault, C. Duby, E. Baéza, C. Diot. Adipogenic genes expression in relation to hepatic steatosis in the liver of two duck species. Animal 2018; 12(12): 2571 doi: 10.1017/S1751731118000897
231
Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj, Anna Mrzljak. Gastrointestinal Complications of Diabetes. Clinical Gastroenterology 2018; : 275 doi: 10.1007/978-3-319-75856-5_21
232
Nadia Soledad Alegre, Cecilia Claudia Garcia, Luis Ariel Billordo, Beatriz Ameigeiras, Daniel Poncino, Javier Benavides, Luis Colombato, Alejandra Claudia Cherñavsky. Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 2020; 26(2): 216 doi: 10.3350/cmh.2019.0074
233
Fatemeh Naeini, Zahra Namkhah, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh-Attar. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease. Advances in Nutrition 2021; 12(2): 413 doi: 10.1093/advances/nmaa106
234
Jacob Beiriger, Kashyap Chauhan, Adnan Khan, Taha Shahzad, Natalia Salinas Parra, Peter Zhang, Sarah Chen, Anh Nguyen, Brian Yan, John Bruckbauer, Dina Halegoua-DeMarzio. Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging Therapies. Livers 2023; 3(4): 637 doi: 10.3390/livers3040042
235
Ana Elenka Ortíz-Reyes, C. Marissa Calderón-Torres. INCREMENTO DE LA EXPRESIÓN DE TLR4 Y EFECTO ANTIOXIDANTE DEL ÁCIDO ACETILSALICÍLICO EN CONEJOS CON DIETA ALTA EN GRASAS. RESPYN Revista Salud Pública y Nutrición 2017; 16(2): 1 doi: 10.29105/respyn16.2-1
236
Johanna Heitmann, Verena G. Frings, Andreas Geier, Matthias Goebeler, Andreas Kerstan. Nicht‐alkoholische Fettlebererkrankung und Psoriasis – besteht ein gemeinsames proinflammatorisches Netzwerk?. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2021; 19(4): 517 doi: 10.1111/ddg.14425_g
237
Xingcen Chen, Ruyi Peng, Dongzi Peng, Jia Xiao, Deliang Liu, Rong Li. An update: is there a relationship between H. pylori infection and nonalcoholic fatty liver disease? why is this subject of interest?. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1282956
238
Pavel Kraml. Lipid-lowering therapy in selected specific groups of patients. Medicína pro praxi 2020; 17(3): 151 doi: 10.36290/med.2020.029
239
Yuanyuan WU, Jingwen ZHOU, Xinchen ZUO, Yufeng KUANG, Lixia SUN, Xiaolong ZHANG. Yanggan Jiangmei Formula alleviates hepatic inflammation and lipid accumulation in non-alcoholic steatohepatitis by inhibiting the NF-κB/NLRP3 signaling pathway. Chinese Journal of Natural Medicines 2024; 22(3): 224 doi: 10.1016/S1875-5364(24)60595-9
240
Fani-Niki Varra, Michail Varras, Viktoria-Konstantina Varra, Panagiotis Theodosis‑Nobelos. Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review). Molecular Medicine Reports 2024; 29(6) doi: 10.3892/mmr.2024.13219
241
Kareem M Abdelraheem, Nahla N Younis, Mohamed A Shaheen, Sahar E Elswefy, Sousou I Ali. Raspberry ketone improves non-alcoholic fatty liver disease induced in rats by modulating sphingosine kinase/sphingosine-1-phosphate and toll-like receptor 4 pathways. Journal of Pharmacy and Pharmacology 2023; 75(7): 985 doi: 10.1093/jpp/rgad044
242
Jennie Ka Ching Lau, Xiang Zhang, Jun Yu. Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances. The Journal of Pathology 2017; 241(1): 36 doi: 10.1002/path.4829
243
Zahra Namkhah, Fatemeh Naeini, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh‐Attar. The association of the adipokine zinc‐alpha2‐glycoprotein with non‐alcoholic fatty liver disease and related risk factors: A comprehensive systematic review. International Journal of Clinical Practice 2021; 75(7) doi: 10.1111/ijcp.13985
244
Patrícia de Castro-de-Paiva, Thatiany de Souza Marinho, Carlos Alberto Mandarim-de-Lacerda, Marcia Barbosa Aguila. Intermittent fasting, high-intensity interval training, or a combination of both have beneficial effects in obese mice with nonalcoholic fatty liver disease. The Journal of Nutritional Biochemistry 2022; 104: 108997 doi: 10.1016/j.jnutbio.2022.108997
245
Maximilian J. Ganz, Sascha T. Bender, Christian Gross, Katrin Bose, Peter R. Mertens, Florian G. Scurt. Metabolisches Syndrom und Nierenkrankheiten. Die Nephrologie 2022; 17(5): 291 doi: 10.1007/s11560-022-00595-6
246
J.E. Davis, J. Cain, C. Small, D.B. Hales. Therapeutic effect of flax-based diets on fatty liver in aged laying hens. Poultry Science 2016; 95(11): 2624 doi: 10.3382/ps/pew160
247
Bai Ruiyang, Adriana Panayi, Wu Ruifang, Zhang Peng, Fu Siqi. Adiponectin in psoriasis and its comorbidities: a review. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01510-z
248
Yohei Owada, Takafumi Tamura, Tomohito Tanoi, Yusuke Ozawa, Yoshio Shimizu, Katsuji Hisakura, Takashi Matsuzaka, Hitoshi Shimano, Noriyuki Nakano, Shingo Sakashita, Toshiya Matsukawa, Hiroko Isoda, Nobuhiro Ohkohchi. Novel non‐alcoholic steatohepatitis model with histopathological and insulin‐resistant features. Pathology International 2018; 68(1): 12 doi: 10.1111/pin.12612
249
Parichehr Amiri, Sara Arefhosseini, Farnush Bakhshimoghaddam, Hannah Jamshidi Gurvan, Seyed Ahmad Hosseini. Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1037696
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345